EFMH
EW icon

E Fund Management (HK)’s Edwards Lifesciences EW Stock Holding History

E Fund Management (HK)’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$362 Hold
4
– – ﹤0.01% 535
2026
Q1 		$320 Hold
4
– – ﹤0.01% 474
2025
Q4 		$331 Hold
4
– – ﹤0.01% 370
2025
Q3 		$311 Buy
+4
New +$313 ﹤0.01% 334

Other funds holding EW

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
NONA
Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
OIAM
OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return
FFM
Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return

E Fund Management (HK)'s EW Position: Q2 2026 in Review

E Fund Management (HK) held its Edwards Lifesciences (EW) position steady in Q2 2026 at 4 shares worth $362. The position accounts for ﹤0.01% of the portfolio, ranked #535.

E Fund Management (HK) first reported a position in EW in Q3 2025 and has held it in 4 quarters since. 287 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • E Fund Management (HK) held 4 shares of Edwards Lifesciences worth $362 as of Q2 2026.
  • E Fund Management (HK) left its Edwards Lifesciences share count unchanged in Q2 2026.
  • Edwards Lifesciences made up ﹤0.01% of E Fund Management (HK)'s portfolio in Q2 2026, its #535 holding.
  • E Fund Management (HK) first reported a position in Edwards Lifesciences in Q3 2025 and has held it in 4 quarters since.
  • 287 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on E Fund Management (HK)'s 13F filing for Q2 2026, filed 22 Jul 2026.